The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
Saved in:
| Title: | The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial. |
|---|---|
| Authors: | Light A; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Kanthabalan A; Division of Surgery & Interventional Science, University College London, London, UK., Otieno M; Division of Surgery & Interventional Science, University College London, London, UK., Pavlou M; Department of Statistical Science, University College London, London, UK., Omar R; Department of Statistical Science, University College London, London, UK., Adeleke S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Giganti F; Division of Surgery & Interventional Science, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK., Brew-Graves C; Division of Medicine, Faculty of Medicine, University College London, London, UK., Williams NR; Division of Surgery & Interventional Science, University College London, London, UK., Emara A; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., Haroon A; Department of Nuclear Medicine, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK., Latifoltojar A; Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, Surrey, UK., Sidhu H; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK; Division of Medicine, Faculty of Medicine, University College London, London, UK., Freeman A; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK., Orczyk C; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK., Nikapota A; Sussex Cancer Centre, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Dudderidge T; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Hindley RG; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., Virdi J; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Arya M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Payne H; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK., Mitra AV; Department of Oncology, University College London Hospital NHS Foundation Trust, London, UK., Bomanji J; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK., Winkler M; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Horan G; Department of Oncology, Queen Elizabeth Hospital, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK., Moore CM; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK., Emberton M; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK., Punwani S; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK; Division of Medicine, Faculty of Medicine, University College London, London, UK., Ahmed HU; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery & Interventional Science, University College London, London, UK., Shah TT; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery & Interventional Science, University College London, London, UK. Electronic address: t.shah@imperial.ac.uk. |
| Source: | European urology [Eur Urol] 2024 Jan; Vol. 85 (1), pp. 35-46. Date of Electronic Publication: 2023 Sep 29. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
